[Federal Register Volume 63, Number 181 (Friday, September 18, 1998)]
[Notices]
[Pages 49916-49917]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-25033]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[INFO-98-29]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call the Assistant
CDC Reports Clearance Officer on (404) 639-7090.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques for other
forms of information technology. Send comments to Seleda M. Perryman,
Assistant CDC Reports Clearance Officer, 1600 Clifton Road, MS-D24,
Atlanta, GA 30333. Written comments should be received within 60 days
of this notice.
Proposed Projects
1. Multi-Center Cohort Study To Assess the Risk and Consequences of
Hepatitis C Virus Transmission From Mother to Infant (0920-0344)--
Extension
The purpose of the study is to determine the incidence of vertical
hepatitis C virus (HCV) transmission, to assess risk factors for
vertical HCV transmission, to assess the clinical course of disease
among infants with HCV infection, and to assess diagnostic methods for
detecting HCV infection in infants. Respondents for the study will be
anti-HCV positive mothers.
There is no cost to the respondents. They will be remunerated for
travel costs; provided well-child visits and free vaccinations for
infants enrolled in the study; and, provided anti-HCV testing to all
family members free of charge.
[[Page 49917]]
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden/ Total
Respondents Form name respondents responses/ response burden (in
respondent (in hours) hours)
----------------------------------------------------------------------------------------------------------------
Individual Mothers................. Form A................. 300 1 0.25 75
Mothers............................ Form B................. 1200 1 0.25 300
Mothers............................ Form C................. 300 1 0.10 30
Family members..................... Form E................. 300 1 0.25 75
Mothers............................ Form G................. 300 8 0.10 240
Total........................ ....................... ........... ........... ........... *720
----------------------------------------------------------------------------------------------------------------
* The annualized response burden is estimated to be 720 hours/4.5 years=160 hours.
AA(Target enrollment in the study is 300; the target population will be drawn from those who complete Form B.
Family members will complete Form E.)
2. Evaluation of Antimicrobial Resistance Testing at National
Nosocomial Infections Surveillance System (NNIS) Laboratories--New
The Hospital Infections Program, National Center for Infectious
Diseases (NCID), Centers for Disease Control and Prevention (CDC), is
proposing to set up an evaluation program to validate the accuracy of
the susceptibility data reported to the NNIS system. New and emerging
mechanisms of antimicrobial resistant are becoming more common
throughout the U.S. hospitals and have resulted in recommended changes
in laboratory testing. However, the timing of changes in testing
techniques commonly lag behind the recommended changes. Therefore, with
antimicrobial resistance becoming more dispersed, validation of testing
techniques is essential. The objectives of this project are to detect
(1) unacceptable or inefficient methods of susceptibility testing, (2)
inaccuracy due to technical difficulties, and (3) ineffective methods
of reporting susceptibility data. The results from this project will
help guide a campaign to improve antimicrobial testing in all U.S.
hospitals. There is no cost to the respondents.
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden/ Total burden
Forms respondents responses/ response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
NNIS Hospital Laboratories.............................. 230 1 0.30 77
Total............................................. ............ ............ ............ 77
----------------------------------------------------------------------------------------------------------------
Dated: September 14, 1998.
Charles Gollmar,
Deputy Director for Policy Planning and Evaluation, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 98-25033 Filed 9-17-98; 8:45 am]
BILLING CODE 4163-18-P
